Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Kangda Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing company based in Meizhou, Guangdong Province, and a subsidiary of Kangmei Pharmaceutical. Founded in 1993, the company specializes in the production of chemical drugs and traditional Chinese medicines (TCM), operating multiple GMP-certified production lines for tablets, capsules, granules, and active pharmaceutical ingredients (APIs). Its product portfolio includes widely used generic medications such as paracetamol and amoxicillin, alongside a variety of TCM formulations targeting respiratory and gastrointestinal health. Following the restructuring of its parent company, Guangdong Kangda has been integrated into the broader supply chain managed by the Guangdong state-owned pharmaceutical consortium. The company remains a significant regional player in the manufacturing and distribution of essential medicines within the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Kangda Pharmaceutical.